title: Reversible cardiogenic shock following 5-fluorouracil infusion.
abstract: 5-Fluorouracil remains a major component of chemotherapy regimens for various tumors. We report the case of reversible cardiogenic shock following 5-FU administration and discuss the different pitfalls of such toxicity. Oncologist should be aware of that rare but potentially lethal adverse event.
authors.affiliation: Phase I unit (SITEP), Department of Medicine, Institut Gustave Roussy, 94805, Villejuif, France. chferte@hotmail.com
authors.forename: Charles
authors.initials: C
authors.lastname: Ferté
authors.forename: Carlos
authors.initials: C
authors.lastname: Gomez Roca
authors.forename: Yohann
authors.initials: Y
authors.lastname: Loriot
authors.forename: Rastislav
authors.initials: R
authors.lastname: Bahleda
authors.forename: Cristian
authors.initials: C
authors.lastname: Moldovan
authors.forename: Ariel
authors.initials: A
authors.lastname: Cohen
authors.forename: Hassan
authors.initials: H
authors.lastname: Izzedine
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Soria
authors.forename: Stephane
authors.initials: S
authors.lastname: Ederhy
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D012770:Shock, Cardiogenic / Q000139:chemically induced*
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil